0001193125-23-064947.txt : 20230309 0001193125-23-064947.hdr.sgml : 20230309 20230308212850 ACCESSION NUMBER: 0001193125-23-064947 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230309 DATE AS OF CHANGE: 20230308 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36297 FILM NUMBER: 23717977 BUSINESS ADDRESS: STREET 1: 1222 DEMONBREUN STREET STREET 2: SUITE 2000 CITY: NASHVILLE STATE: TN ZIP: 37203 BUSINESS PHONE: 6157247755 MAIL ADDRESS: STREET 1: 1222 DEMONBREUN STREET STREET 2: SUITE 2000 CITY: NASHVILLE STATE: TN ZIP: 37203 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Foley Mark J CENTRAL INDEX KEY: 0001529196 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: ZELTIQ AESTHETICS INC. STREET 2: 4698 WILLOW ROAD SUITE 100 CITY: PLEASANTON STATE: CA ZIP: 94588 144 1 primary_doc.xml 144 0001529196 XXXXXXXX LIVE 0001479290 Revance Therapeutics, Inc. 001-36297 1222 Demonbreun St Suite 2000 Nashville TN 37203 615-724-7755 Mark Foley Officer Common E*TRADE FINANCIAL CORPORATION 3 EDISON DRIVE ALPHARETTA GA 30005 75000 2475000.00 82800000 03/08/2023 NASD Revance Common 03/07/2023 RSU Vesting Revance Therapeutics N 75000 03/07/2023 cash Y Shares sold to cover taxes from a RSU vest 03/08/2023 /s/ Dwight Moxie, Attorney-in-Fact